XML 43 R33.htm IDEA: XBRL DOCUMENT v3.20.2
Financial instruments (Details 4)
$ in Millions
6 Months Ended
Jun. 30, 2020
USD ($)
Novartis Capital Corporation, New York, United States, 1.75%, 2025 [member]  
Disclosure of detailed information about borrowings [line items]  
Borrowings, coupon 1.75%
Borrowings, original currency USD
Notional amount $ 1,000
Borrowings, maturity year 2025
Borrowings, issuer Novartis Capital Corporation, New York, United States
Borrowings, issue price 99.852%
Straight bonds $ 996
Novartis Capital Corporation, New York, United States, 2.00%, 2027 [member]  
Disclosure of detailed information about borrowings [line items]  
Borrowings, coupon 2.00%
Borrowings, original currency USD
Notional amount $ 1,250
Borrowings, maturity year 2027
Borrowings, issuer Novartis Capital Corporation, New York, United States
Borrowings, issue price 99.909%
Straight bonds $ 1,245
Novartis Capital Corporation, New York, United States, 2.20%, 2030 [member]  
Disclosure of detailed information about borrowings [line items]  
Borrowings, coupon 2.20%
Borrowings, original currency USD
Notional amount $ 1,500
Borrowings, maturity year 2030
Borrowings, issuer Novartis Capital Corporation, New York, United States
Borrowings, issue price 99.869%
Straight bonds $ 1,492
Novartis Capital Corporation, New York, United States, 2.75%, 2050 [member]  
Disclosure of detailed information about borrowings [line items]  
Borrowings, coupon 2.75%
Borrowings, original currency USD
Notional amount $ 1,250
Borrowings, maturity year 2050
Borrowings, issuer Novartis Capital Corporation, New York, United States
Borrowings, issue price 97.712%
Straight bonds $ 1,213